We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Applied Sciences

CARB-X

CARB-X accelerates global antibacterial innovation by supporting the development of new antibiotics and other life-saving products.

Latest Content

Researchers reviewing data on a tablet in a modern laboratory with microscopes and equipment.

Product News

Researchers Develop Antibiotics for Resistant Infections

Researchers are developing a new class of antibiotics that target lipoprotein transport in Gram-negative bacteria such as E. coli and Klebsiella pneumoniae, aiming to treat infections resistant to many current drugs.

Illustration of typhoid bacteria against a soft gradient background.

Product News

Rapid IgA Test Aims To Improve Typhoid Diagnosis

CARB-X is investing $1.8 million to support development of a rapid blood-based IgA test targeting two biomarkers of Salmonella Typhi, designed to distinguish acute infection from past exposure and improve care in low-resource settings.

Never miss a story

with the Breaking Science News daily newsletter